Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 10, 1998, Pages 1099-1106

  Uribe, M ^a   Moran S ^a   Poo, J L ^a   Mendez SAnchez N ^a   Guevara, L ^a   Garcia Ramos G ^a  

^a LIVER RESEARCH UNIT   (Mexico)

Author keywords

Amylase inhibitor; Disaccharidase inhibitors; Liver coma; Liver failure; Malabsorption; Maltase inhibitor; Portal systemic encephalopathy

Indexed keywords

VOGLIBOSE;

ADJUVANT THERAPY; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; BREATH ANALYSIS; CARBOHYDRATE INTOLERANCE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; FECES ANALYSIS; FEMALE; FLAPPING TREMOR; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; NITROGEN BALANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CYCLOHEXANOLS; DISACCHARIDASES; DISACCHARIDES; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED;

EID: 0031787095     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655298750026822     Document Type: Article

References (35)

1. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factors in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987;6:1-12.
2. Zieve L, Doizaki WM, Zieve FJ. Synergism between mercaptans and ammonia and fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974;83:16-28.
3. Fischer JE, Baidessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-9.
4. Zerenoli ML. Hepatic encephatopathy. J Hepatol 1985;1:301-12.
5. Sparhr L, Butterworth R, Fontaine SBL, Therrien G, Milette P, Lebrun L, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996;24:1116-20.
6. Uribe M. Treatment of portal systemic encephalopathy. The old and new treatments. In Grisolia S, editor. Cirrhosis, hepatic encephalopathy and ammonium toxicity. New York: Plenum Publishing Corp; 1991. p. 235-53.
7. Ballongue J, Schumann C, Quignon P. Effects of lactulose and lactitol on colonie microflora and enzymatic activity. Scand J Gastroenterol 1997;32 Suppl 222:41-44.
8. Uribe-Esquivel M, Moran S, Poo JL, Muñoz RM. In vitro and in vivo lactose and lactulose effects on colonie fermentation and portal-systemic encephalopathy parameters. Scand J Gastroenterol 1997;32 Suppl 222:49-52.
9. Morgan MY, Hawley KE. Lactitol vs lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind, randomized trial. Hepatology 1987;7:1278-89.
10. Morgan MY, Hawley KE, Stambuck D. Lactitol versus lactose in the treatment of chornic hepatic encephalopathy: a double blind randomized cross over study. J Hepatol 1987;4:236-44.
11. Salminen S, Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J. Gastroenterol 1997;32 Suppl 222:45-48.
12. Greenberger NJ, Carley J, Schencker S, Bettenger I, Stamnes C, Bayer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis 1977;22:845-55.
13. Uribe M, Marquez MA, García-Ramos G, Ramos-Uribe MH, Vargas F, Villalobos A, et al. Treatment of chronic portal systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982;27:1109-16.
14. Keshavarzian A, Meek J, Sutton VM, Emery VM, Hughes EA, Hodson HJ. Dietary supplementation from vegetable sources in the management of chronic portal systemic encephalopaty. Am J. Gastroenterol 1984;79:945-9.
15. DeBrujin KM, Blendis LM, Zilm DH, Carles PL, Anderson GH. Effect of dietary manipulations on subclinical portal systemic encephalopathy. Gut 1983;24:53-60.
16. Uribe M, Dibildox M, Malpica S, Villalobos A, Nieto L, Vargas F, et al. Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology 1985;88:901-7.
17. Ladas SD, Frydas A, Papadopulos A, Raptis SA. Effects of alpha glucosidase inhibitors on mouth to cecum transit time in humans. Gut 1992;33:1246-8.
18. Goto Y, Yamada K, Ohyama T, Matsuo T, Odaka H, Ikeda H. An alpha-glucosidade inhibitor, AO-128, retards carbohydrate absorption in rats and humans. Diabetes Res Clin Pract 1995;28: 81-7.
19. Weber F, Banwell JG, Fresard KM, Cummings JH. Nitrogen in fecal bacterial, fiber and soluble fractions of patients with cirrhosis. Effects of lactulose and lactulose plus neomycin. J Lab Clin Med 1987;110:259-63.
20. Uribe M, Berthier JM, Lewis H, Mata JM, Sierra JG, Garcia-Ramos G, et al. Lactose enemas plus placebo tablets vs neomycin tablets plus starch enemas in acute portal systemic encephalopathy: a double blind randomized controlled study. Gastroenterology 1981;81:101-6.
21. Uribe M, Orozco H, Moran S, Guevara L, Poo JL, Vargas-Vorackova F. Portal systemic encephalopathy and gastrointestinal bleeding alter cardioselective beta blocker (metoprolol) administration to patients with portal hypertension. Arch Med Res 1995;26:221-6.
22. Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Law D, et al. Comparison of dietary protein with an oral branched chain-enriched amino acid supplement in chronic, portal-systemic encephalopathy: double-blind controlled trial. Hepatology 1984; 4:279-87.
23. Riggio O, Balducci G, Ariosto F, Merli M, Picche U, Pinto G, et al. Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Dig Dis Sci 1989;34:823-9.
24. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched-chain amino acid treatment in chronic encephalopathy. A randomised double-blind casein controlled-trial. J Hepatol 1990;11:92-101.
25. Conn HO. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541-50.
26. Mondzac A, Ehrlich GE, Seegmiller JE. An enzymatic determination of ammonia in biological fluids. J. Lab Clin Med 1965; 66:526-31.
27. Conn HO. Measurement of stool pH. In: Conn HO, Lieberthal HM, editors. Hepatic coma syndromes and lactulose. Baltimore (MD): Williams and Wilkins; 1979. p. 295-305.
28. Rosado JL. Analisis de hidrógeno espirado como indice de absorción de curbohidratos. Rev Inv Clin 1985;37:261-70.
29. Hiller A, Plazin J, Van Slyke D. A study of conditions for Kjeldahl determination of nitrogen in protein. J Biol Chem 1948;176:1401-16.
30. Hiele M, Ghoos Y, Rutgeerts P, Vantrappen G. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileos tomy patients, and in vitro. Dig Dis Sci 1992;37:1057-64.
31. Uribe M, Campollo O, Cote C. Effect of lactulose on the metabolism of short-chain fatty acids. Hepatology 1990;12: 1251-2.
32. Mortensen PB, Holtug K, Bonnen H, Clausen MR. The degradation of amino-acids, proteins and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 1980;98:353-60.
33. Zillikerns MC, Swart GR, vand den Berg JW, Wilson JH. Effects of the glucosidase inhibitor acarbose in patient with liver cirrhosis. Aliment Pharmacol Ther 1989;3:453-9.
34. Norgaard I, Hansen BS, Mortensen PB. Colonic fermentation of complex dietary carbohydrates in short-bowel patients. No association with hydrogen excretion and fecal and plasma short-chain fatty acids. Scand J Gastroenterol 1995;30:897-904.
35. Vogelsang H, Ferenci P, Frotz S, Meryn S, Gangl A. Acid colonic microclimate-possible reason for false negative hidrogen breath test. Gut 1988;29:21-6.